Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on oligonucleotides?

Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on oligonucleotides?

Submitted by admin on April 30, 2024 - 11:18am
Source: 
Biopharma Reporter
News Tags: 
RNA
biotech
Asia-Pacific
Headline: 
Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on oligonucleotides?
snippet: 

A recent study finds RNA deals are “dominated” by oligonucleotides and mRNA vaccines in APAC

Do Not Allow Advertisers to Use My Personal information